Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00860041 · ClinicalTrials.gov registry record
Acute Pain Caused by Paclitaxel in Patients With Cancer
A clinical trial, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- 306
- Enrollment target
NCT00860041: Completed study, sponsored by Alliance for Clinical Trials in Oncology.
NCT00860041 is a clinical trial that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 306 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00860041 has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- 306 participants
- Enrollment target
Study Summary
RATIONALE: Gathering information over time from patients receiving paclitaxel for cancer may help doctors learn more about pain caused by paclitaxel and plan the best treatment. PURPOSE: This clinical trial is studying acute pain caused by paclitaxel in patients with cancer.
Interventions
- BEHAVIORAL pain questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 306 participants |
| Start Date | 2009-02 |
| Est. Completion | 2013-05 |
What the finished NCT00860041 record still lists
NCT00860041 is an observational study that tracks outcomes without assigning an intervention. The registered 306 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which pain questionnaires is the first listed.
NCT00860041 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00860041 about?
NCT00860041 is a clinical study titled "Acute Pain Caused by Paclitaxel in Patients With Cancer". RATIONALE: Gathering information over time from patients receiving paclitaxel for cancer may help doctors learn more about pain caused by paclitaxel and plan the best treatment. PURPOSE: This clinical trial is studying acute pain caused by paclitaxel in patients with cancer.
What is the current status of trial NCT00860041?
This trial is currently completed. The enrollment target is 306 participants. The study started on 2009-02. Estimated completion is 2013-05.
What interventions are being tested in trial NCT00860041?
The interventions under investigation include: pain questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT00860041?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05078970 · 306 participants · NA
Advancing Suicide Intervention Strategies for Teens During High Risk Periods
- NCT05843695 · 306 participants · NA
Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety
- NCT06057337 · 306 participants · NA
Families With Pride ("Familias Con Orgullo").
- NCT06498635 · 306 participants · Phase 3
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia